303 related articles for article (PubMed ID: 23014881)
41. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
42. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
43. Alkaloid uptake pathways in renal tubular epithelial cells from different processed products of Phellodendri chinensis Cortex.
Ge XT; Zhao JH; Ren WJ; Zhou Y; Chen Y; Jiang SR; Jia TZ; Gao H; Zhang F
J Pharm Biomed Anal; 2024 May; 242():116014. PubMed ID: 38367517
[TBL] [Abstract][Full Text] [Related]
44. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.
Poller B; Gutmann H; Krähenbühl S; Weksler B; Romero I; Couraud PO; Tuffin G; Drewe J; Huwyler J
J Neurochem; 2008 Dec; 107(5):1358-68. PubMed ID: 19013850
[TBL] [Abstract][Full Text] [Related]
45. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
[TBL] [Abstract][Full Text] [Related]
46. The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein.
Gonçalves P; Gregório I; Martel F
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C984-94. PubMed ID: 21775706
[TBL] [Abstract][Full Text] [Related]
47. Cobalt Chloride Induces Expression and Function of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Renal Proximal Tubular Epithelial Cell Line HK-2.
Nishihashi K; Kawashima K; Nomura T; Urakami-Takebayashi Y; Miyazaki M; Takano M; Nagai J
Biol Pharm Bull; 2017; 40(1):82-87. PubMed ID: 28049953
[TBL] [Abstract][Full Text] [Related]
48. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
49. Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells.
Karla PK; Earla R; Boddu SH; Johnston TP; Pal D; Mitra A
Curr Eye Res; 2009 Jan; 34(1):1-9. PubMed ID: 19172464
[TBL] [Abstract][Full Text] [Related]
50. Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier.
Robillard KR; Hoque T; Bendayan R
J Pharmacol Exp Ther; 2012 Jan; 340(1):96-108. PubMed ID: 21990609
[TBL] [Abstract][Full Text] [Related]
51. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
Graber-Maier A; Gutmann H; Drewe J
Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
[TBL] [Abstract][Full Text] [Related]
52. Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transporters.
Järvinen E; Sjöstedt N; Koenderink JB; Kidron H; Finel M
Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):490-498. PubMed ID: 31237077
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
[TBL] [Abstract][Full Text] [Related]
54. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
55. Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid.
Ren G; Qin Z; Yang N; Chen H; Fu K; Lu C; Lu Y; Li N; Zhang Y; Chen X; Zhao D
Chem Biol Interact; 2020 Jun; 324():109097. PubMed ID: 32305507
[TBL] [Abstract][Full Text] [Related]
56. Interplay of metabolizing enzymes and transporter of xenobiotics.
Lim HY; Ho QS; Wong KP
Xenobiotica; 2016; 46(1):25-33. PubMed ID: 26226519
[TBL] [Abstract][Full Text] [Related]
57. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
Ernest S; Bello-Reuss E
Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
[TBL] [Abstract][Full Text] [Related]
58. Blood-brain barrier transporters and response to CNS-active drugs.
Urquhart BL; Kim RB
Eur J Clin Pharmacol; 2009 Nov; 65(11):1063-70. PubMed ID: 19727692
[TBL] [Abstract][Full Text] [Related]
59. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
60. Expression and Function of ABC Transporters in Human Alveolar Epithelial Cells.
Visigalli R; Rotoli BM; Ferrari F; Di Lascia M; Riccardi B; Puccini P; Dall'Asta V; Barilli A
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
